Neurology clinical trials recruiting in Pennsylvania

108 recruiting neurology trials match in Pennsylvania. Showing 20.

• STXBP1 and SYNGAP1 Related Disorders Natural History StudyRecruiting

  N/A · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania

• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)Recruiting

  N/A · TG Therapeutics, Inc. · Bethlehem, Pennsylvania

• A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor ComplicationsRecruiting

  N/A · InSightec · Philadelphia, Pennsylvania

• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1Recruiting

  Phase 3 · Rapport Therapeutics Inc. · Philadelphia, Pennsylvania

• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic SeizuresRecruiting

  Phase 3 · Xenon Pharmaceuticals Inc. · Philadelphia, Pennsylvania

• Epilepsy Learning Healthcare System (ELHS)Recruiting

  N/A · Epilepsy Foundation of America · Hershey, Pennsylvania

• Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)Recruiting

  Phase 3 · AbbVie · Philadelphia, Pennsylvania

• Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15Recruiting

  Early Phase 1 · University of Pennsylvania · Philadelphia, Pennsylvania

• Effects of Amazonian Dance on Motor and Non-motor Symptoms of People With Parkinson's: Study ProtocolRecruiting

  N/A · Federal University of Rio Grande do Sul · Castanhal, Pennsylvania

• Evaluating the Effectiveness of the Health App Recommendation ToolRecruiting

  N/A · University of Pittsburgh · Pittsburgh, Pennsylvania

• TSC Biosample Repository and Natural History DatabaseRecruiting

  N/A · National Tuberous Sclerosis Association · Philadelphia, Pennsylvania

• A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset SeizuresRecruiting

  Phase 2 · Rapport Therapeutics Inc. · Philadelphia, Pennsylvania

• Localizing Epileptic Networks Using MRI and iEEGRecruiting

  Early Phase 1 · University of Pennsylvania · Philadelphia, Pennsylvania

• Deep Brain Stimulation (DBS) Retrospective Outcomes StudyRecruiting

  N/A · Boston Scientific Corporation · Pittsburgh, Pennsylvania

• Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and AdultsRecruiting

  Phase 3 · SK Life Science, Inc. · Philadelphia, Pennsylvania

• A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)Recruiting

  Phase 3 · Merck Sharp & Dohme LLC · Philadelphia, Pennsylvania

• AMX0114 in Adult Participants With Amyotrophic Lateral SclerosisRecruiting

  Phase 1 · Amylyx Pharmaceuticals Inc. · Philadelphia, Pennsylvania

• Impact of a Biophoton Therapy on Patients With Brain DisordersRecruiting

  N/A · First Institute of All Medicines · Butler, Pennsylvania

• Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)Recruiting

  Phase 1 / Phase 2 · Merck Sharp & Dohme LLC · Pittsburgh, Pennsylvania

• A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)Recruiting

  Phase 1 / Phase 2 · Merck Sharp & Dohme LLC · Pittsburgh, Pennsylvania

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.